|
EP4282419A1
(en)
|
2012-12-20 |
2023-11-29 |
Purdue Research Foundation |
Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
|
|
AU2013204922B2
(en)
|
2012-12-20 |
2015-05-14 |
Celgene Corporation |
Chimeric antigen receptors
|
|
CA2907397C
(en)
|
2013-03-15 |
2022-11-22 |
Anthrogenesis Corporation |
Modified t lymphocytes
|
|
KR102211120B1
(ko)
|
2014-05-15 |
2021-02-03 |
내셔널 유니버시티 오브 싱가포르 |
변형된 천연 살해 세포 및 그의 용도
|
|
US10034872B2
(en)
*
|
2014-08-22 |
2018-07-31 |
Celgene Corporation |
Methods of treating multiple myeloma with immunomodulatory compounds in combination with antibodies
|
|
KR102236843B1
(ko)
|
2014-12-01 |
2021-04-07 |
수마 헬스 |
새로운 재생 치료제로서의 camkk1
|
|
US10632151B2
(en)
|
2015-01-22 |
2020-04-28 |
University Of Massachusetts |
Cancer immunotherapy
|
|
CA2986765A1
(en)
|
2015-05-29 |
2016-12-08 |
Agenus Inc. |
Anti-ctla-4 antibodies and methods of use thereof
|
|
US12590321B2
(en)
|
2016-03-19 |
2026-03-31 |
Exuma Biotech Corp. |
Methods and compositions for genetically modifying and expanding lymphocytes and regulating the activity thereof
|
|
US11325948B2
(en)
|
2016-03-19 |
2022-05-10 |
Exuma Biotech Corp. |
Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of MPL
|
|
US11111505B2
(en)
|
2016-03-19 |
2021-09-07 |
Exuma Biotech, Corp. |
Methods and compositions for transducing lymphocytes and regulating the activity thereof
|
|
US12144850B2
(en)
|
2016-04-08 |
2024-11-19 |
Purdue Research Foundation |
Methods and compositions for car T cell therapy
|
|
JP7373991B2
(ja)
*
|
2016-07-15 |
2023-11-06 |
ビラクタ セラピューティクス，インク． |
免疫療法で使用するためのヒストン脱アセチル化酵素阻害剤
|
|
KR102576042B1
(ko)
|
2016-10-11 |
2023-09-07 |
아게누스 인코포레이티드 |
항-lag-3 항체 및 이의 사용 방법
|
|
CA3037046A1
(en)
|
2016-10-31 |
2018-05-03 |
University Of Massachusetts |
Targeting microrna-101-3p in cancer therapy
|
|
CN118634323A
(zh)
|
2016-12-07 |
2024-09-13 |
艾吉纳斯公司 |
抗体和其使用方法
|
|
FI3551660T3
(fi)
|
2016-12-07 |
2023-12-11 |
Agenus Inc |
Anti-ctla-4-vasta-aineita ja niiden käyttömenetelmiä
|
|
ES2875005T3
(es)
|
2016-12-09 |
2021-11-08 |
Onk Therapeutics Ltd |
Células asesinas naturales manipuladas y usos de las mismas
|
|
WO2018121679A1
(zh)
*
|
2016-12-30 |
2018-07-05 |
四川大学 |
表达cxcr4的嵌合抗原受体修饰的淋巴细胞及制备方法和用途
|
|
ES3010559T3
(en)
|
2017-02-28 |
2025-04-03 |
Endocyte Inc |
Compositions and methods for car t cell therapy
|
|
IL269553B2
(en)
|
2017-03-27 |
2025-10-01 |
Nat Univ Singapore |
Truncated NKG2D chimeric receptors and their uses in immunotherapy with natural killer cells
|
|
WO2018177971A1
(en)
*
|
2017-03-27 |
2018-10-04 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method to obtain lymphoid progenitors
|
|
WO2018182511A1
(en)
|
2017-03-27 |
2018-10-04 |
National University Of Singapore |
Stimulatory cell lines for ex vivo expansion and activation of natural killer cells
|
|
BR112019024656A2
(pt)
*
|
2017-05-25 |
2020-06-09 |
Univ Central Florida Res Found Inc |
vírus oncolíticos para a sensibilização de células tumorais para morte por células exterminadoras naturais
|
|
TWI676483B
(zh)
*
|
2017-08-06 |
2019-11-11 |
強普生技股份有限公司 |
醫藥套組及其用途
|
|
CA3077325A1
(en)
*
|
2017-09-28 |
2019-04-04 |
Celularity Inc. |
Tumor suppression using human placenta-derived intermediate natural killer (pink) cells in combination with an antibody
|
|
AU2018346818B2
(en)
*
|
2017-10-02 |
2024-12-19 |
Gamida-Cell Ltd. |
Expansion and use of expanded NK cell fractions
|
|
CN111542545A
(zh)
*
|
2017-11-03 |
2020-08-14 |
索伦托治疗有限公司 |
Cd38定向嵌合抗原受体构建体
|
|
JP2021505637A
(ja)
*
|
2017-12-12 |
2021-02-18 |
マクロジェニクス，インコーポレーテッド |
二重特異性ｃｄ１６結合分子、及び疾患の治療におけるその使用
|
|
CN108060137B
(zh)
*
|
2017-12-26 |
2021-07-02 |
博生吉医药科技(苏州)有限公司 |
Il7和il21修饰的nk92细胞、制备方法及其应用
|
|
WO2019127215A1
(en)
*
|
2017-12-28 |
2019-07-04 |
Nanjing Legend Biotech Co., Ltd. |
Multispecific chimeric receptors comprising an nkg2d domain and methods of use thereof
|
|
NZ749727A
(en)
*
|
2018-01-05 |
2020-07-31 |
Gnt Biotech & Medicals Corp |
A pharmaceutical combination and method for regulation of tumor microenvironment and immunotherapy
|
|
US11311576B2
(en)
|
2018-01-22 |
2022-04-26 |
Seattle Children's Hospital |
Methods of use for CAR T cells
|
|
US11814623B2
(en)
|
2018-01-30 |
2023-11-14 |
University Of Massachusetts |
Methods of treating a wound using epigenetic regulation
|
|
AU2019215034C1
(en)
|
2018-02-01 |
2022-01-06 |
Nkmax Co., Ltd. |
Method of producing natural killer cells and composition for treating cancer
|
|
CN111801348A
(zh)
|
2018-02-09 |
2020-10-20 |
新加坡国立大学 |
活化性嵌合受体及其在自然杀伤细胞免疫疗法中的用途
|
|
WO2019165121A1
(en)
|
2018-02-21 |
2019-08-29 |
Board Of Regents, The University Of Texas System |
Methods for activation and expansion of natural killer cells and uses therof
|
|
CA3091674A1
(en)
|
2018-02-23 |
2019-08-29 |
Endocyte, Inc. |
Sequencing method for car t cell therapy
|
|
WO2019183094A1
(en)
*
|
2018-03-19 |
2019-09-26 |
The Regents Of The University Of Michigan |
Compositions and methods for t-cell and cytokine activation
|
|
SG11202008976YA
(en)
|
2018-04-02 |
2020-10-29 |
Nat Univ Singapore |
Neutralization of human cytokines with membrane-bound anti-cytokine non-signaling binders expressed in immune cells
|
|
IL277773B2
(en)
|
2018-04-18 |
2026-05-01 |
Summa Health |
Compositions and methods for treating ischemia and cardiomyopathy
|
|
WO2019200586A1
(en)
*
|
2018-04-19 |
2019-10-24 |
The Chinese University Of Hong Kong |
Modified nk cells and uses thereof
|
|
GB201807050D0
(en)
*
|
2018-04-30 |
2018-06-13 |
Cellprotect Nordic Pharmaceuticals Ab |
Medical uses
|
|
KR102373502B1
(ko)
*
|
2018-05-14 |
2022-03-11 |
주식회사 금호에이치티 |
골수유래억제세포 관련 질환의 예방 및 치료 용도
|
|
KR102069704B1
(ko)
*
|
2018-05-16 |
2020-01-23 |
고려대학교 산학협력단 |
Hdac 억제제를 이용한 사람 유래 자연살해세포의 확장 배양법
|
|
KR20210016567A
(ko)
*
|
2018-05-30 |
2021-02-16 |
글리코스템 떼라퓨틱스 비.브이. |
Car nk 세포
|
|
EP3806894A4
(en)
|
2018-06-12 |
2022-06-08 |
Promab Biotechnologies, Inc. |
PLAP-CAR EFFECTOR CELLS
|
|
CN108815186A
(zh)
*
|
2018-06-14 |
2018-11-16 |
上海鸣大生物科技有限公司 |
一种治疗hpv持续感染引起疾病的药物及制备方法与应用
|
|
EP3844186A4
(en)
|
2018-08-29 |
2022-08-17 |
National University of Singapore |
METHOD OF SPECIFIC STIMULATION OF SURVIVAL AND EXPANSION OF GENETICALLY MODIFIED IMMUNE CELLS
|
|
SG11202102272UA
(en)
|
2018-09-05 |
2021-04-29 |
Univ Arizona State |
Oncolytic virus platform to treat hematological cancer
|
|
AU2019361096A1
(en)
|
2018-10-19 |
2021-06-03 |
Regents Of The University Of Minnesota |
NK engager molecules and methods of use thereof
|
|
WO2020088631A1
(en)
|
2018-11-01 |
2020-05-07 |
Gracell Biotechnologies (Shanghai) Co., Ltd. |
Compositions and methods for t cell engineering
|
|
CA3120563A1
(en)
|
2018-11-26 |
2020-06-04 |
Nkarta, Inc. |
Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy
|
|
EP3886876A1
(en)
*
|
2018-11-30 |
2021-10-06 |
Celularity Inc. |
Placenta-derived allogeneic car-t cells and uses thereof
|
|
WO2020180882A1
(en)
|
2019-03-05 |
2020-09-10 |
Nkarta, Inc. |
Cd19-directed chimeric antigen receptors and uses thereof in immunotherapy
|
|
CA3133419A1
(en)
*
|
2019-03-21 |
2020-09-24 |
Gamida Cell Ltd. |
Expansion and use of expanded nk cell fractions suitable for transplantation in combination therapy
|
|
WO2020223445A1
(en)
|
2019-04-30 |
2020-11-05 |
Senti Biosciences, Inc. |
Chimeric receptors and methods of use thereof
|
|
WO2021016621A1
(en)
*
|
2019-07-25 |
2021-01-28 |
Celularity Inc. |
Populations of natural killer cells comprising a cd38 chimeric antigen receptor
|
|
BR112022003617A2
(pt)
*
|
2019-09-01 |
2022-09-13 |
Exuma Biotech Corp |
Métodos e composições para a modificação e distribuição de linfócitos
|
|
KR20220078665A
(ko)
*
|
2019-10-10 |
2022-06-10 |
아리조나 보드 오브 리젠츠 온 비하프 오브 아리조나 스테이트 유니버시티 |
다중특이적 면역 세포 인게이저를 발현하는 종양용해 바이러스
|
|
EP4065144A4
(en)
*
|
2019-11-27 |
2024-04-10 |
Deverra Therapeutics Inc. |
COMPOSITIONS AND METHODS FOR CULTIVATION OF HEMATOPOETIC STEM CELLS AND PROGENITOR CELLS
|
|
JP2023504075A
(ja)
*
|
2019-11-28 |
2023-02-01 |
グリコステム セラピューティクス ベスローテン フェンノートシャップ |
Ｃａｒ－ｎｋ細胞を得る方法
|
|
US20230111159A1
(en)
*
|
2020-03-05 |
2023-04-13 |
Exuma Biotech Corp |
Methods and compositions for the delivery of modified lymphocyte aggregates
|
|
WO2021188836A1
(en)
*
|
2020-03-18 |
2021-09-23 |
Barron Annelise E |
Upregulation of cathelicidin gene expression as an adjuvant to other treatments for diseases
|
|
GB2621653A
(en)
*
|
2020-09-22 |
2024-02-21 |
World Biotech Regenerative Medical Group Ltd |
Methods and compositions of car-expressing natural killer cells with bispecific antigen-binding molecules as cancer therapeutic agents
|
|
US11459372B2
(en)
|
2020-11-30 |
2022-10-04 |
Crispr Therapeutics Ag |
Gene-edited natural killer cells
|
|
US11473060B2
(en)
|
2020-12-30 |
2022-10-18 |
Crispr Therapeutics Ag |
Compositions and methods for differentiating stem cells into NK cells
|
|
AU2022218710A1
(en)
*
|
2021-02-09 |
2023-08-10 |
Takeda Pharmaceutical Company Limited |
Methods and compositions for freezing and thawing mammalian cells
|
|
WO2022173737A1
(en)
|
2021-02-09 |
2022-08-18 |
Millennium Pharmaceuticals, Inc. |
Methods and compositions for freezing and thawing mammalian cells
|
|
CN113398264B
(zh)
*
|
2021-08-06 |
2022-04-29 |
朱有建 |
Nk细胞及其组合物在治疗癌症中的用途
|
|
US20240335472A1
(en)
*
|
2021-08-10 |
2024-10-10 |
Gamida Cell Ltd. |
Anti-her2 car nk cells, methods of their production and uses thereof
|
|
CN113577267B
(zh)
*
|
2021-09-06 |
2022-04-08 |
江西北正干细胞生物科技有限公司 |
Nk细胞和抗体的药物组合物及其在治疗癌症中的用途
|
|
JPWO2023038037A1
(enExample)
*
|
2021-09-08 |
2023-03-16 |
|
|
|
EP4180049A1
(en)
*
|
2021-11-16 |
2023-05-17 |
Ostravska univerzita |
Therapeutic composition for cancer treatment
|
|
CN114058584B
(zh)
*
|
2022-01-07 |
2022-07-01 |
山东省齐鲁干细胞工程有限公司 |
一种临床用自然杀伤细胞的制备方法
|
|
CN115927169B
(zh)
*
|
2022-10-11 |
2023-08-11 |
再造再生医学科技(杭州)有限公司 |
用于扩增cd34+造血干细胞的培养液和体外扩增cd34+造血干细胞的方法
|
|
CN119082021B
(zh)
*
|
2024-09-30 |
2025-03-28 |
广东壹加再生医学研究院有限公司 |
一种增强型nk细胞及其制备方法
|
|
CN119280423A
(zh)
*
|
2024-10-10 |
2025-01-10 |
中南大学 |
一种联合靶向鼻咽癌治疗的载药体系及其制备方法与应用
|
|
CN121426926A
(zh)
*
|
2025-10-21 |
2026-01-30 |
北京京科信拓生物技术有限公司 |
基因编辑的免疫细胞及其应用
|
|
CN121378506A
(zh)
*
|
2025-10-21 |
2026-01-23 |
北京京科信拓生物技术有限公司 |
表达car的免疫细胞及其应用
|